ATE215559T1 - Peralkylierte oligopeptidmischungen - Google Patents

Peralkylierte oligopeptidmischungen

Info

Publication number
ATE215559T1
ATE215559T1 AT94920718T AT94920718T ATE215559T1 AT E215559 T1 ATE215559 T1 AT E215559T1 AT 94920718 T AT94920718 T AT 94920718T AT 94920718 T AT94920718 T AT 94920718T AT E215559 T1 ATE215559 T1 AT E215559T1
Authority
AT
Austria
Prior art keywords
peralkylated
amino acid
sets
acid residues
chain
Prior art date
Application number
AT94920718T
Other languages
English (en)
Inventor
Richard A Houghten
John M Ostresh
Sylvie Blondelle
Original Assignee
Torrey Pines Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/079,144 external-priority patent/US5846731A/en
Application filed by Torrey Pines Inst filed Critical Torrey Pines Inst
Application granted granted Critical
Publication of ATE215559T1 publication Critical patent/ATE215559T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT94920718T 1993-06-17 1994-06-10 Peralkylierte oligopeptidmischungen ATE215559T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/079,144 US5846731A (en) 1993-06-17 1993-06-17 Peralkylated oligopeptide mixtures
US08/257,782 US5480971A (en) 1993-06-17 1994-06-09 Peralkylated oligopeptide mixtures
PCT/US1994/006554 WO1995000539A1 (en) 1993-06-17 1994-06-10 Peralkylated oligopeptide mixtures

Publications (1)

Publication Number Publication Date
ATE215559T1 true ATE215559T1 (de) 2002-04-15

Family

ID=26761660

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94920718T ATE215559T1 (de) 1993-06-17 1994-06-10 Peralkylierte oligopeptidmischungen

Country Status (7)

Country Link
US (2) US5480971A (de)
EP (1) EP0722458B1 (de)
AT (1) ATE215559T1 (de)
AU (1) AU694438B2 (de)
CA (1) CA2165561C (de)
DE (1) DE69430312T2 (de)
WO (1) WO1995000539A1 (de)

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2289194T3 (es) * 1993-05-27 2008-02-01 Aventis Pharmaceuticals Inc. Bibliotecas en fase solida codificadas, segregadas topologicamente.
US7820798B2 (en) * 1994-11-07 2010-10-26 Human Genome Sciences, Inc. Tumor necrosis factor-gamma
US7597886B2 (en) * 1994-11-07 2009-10-06 Human Genome Sciences, Inc. Tumor necrosis factor-gamma
US5919897A (en) * 1995-06-07 1999-07-06 Torrey Pines Institute For Molecular Studies MU opioid receptor ligands: agonists and antagonists
AU720632B2 (en) * 1996-03-05 2000-06-08 Trega Biosciences, Inc. Selectively N-alkylated peptidomimetic combinatorial libraries and compounds therein
US6777217B1 (en) * 1996-03-26 2004-08-17 President And Fellows Of Harvard College Histone deacetylases, and uses related thereto
DK0961831T3 (da) 1996-08-16 2009-01-12 Human Genome Sciences Inc Humant alfa-endokin
EP0963377B1 (de) 1996-08-30 2009-03-04 Human Genome Sciences, Inc. Interleukin-19.
US6183988B1 (en) 1996-10-02 2001-02-06 The General Hospital Corporation Leukocyte-specific protein and gene, and methods of use thereof
CA2665133A1 (en) 1996-10-25 1998-05-07 Human Genome Sciences, Inc. Neutrokine .alpha.
EP0941335A2 (de) 1996-10-31 1999-09-15 Human Genome Sciences Polynukleotide und sequenzen aus streptococcus pneumoniae
ES2308800T3 (es) * 1997-01-08 2008-12-01 Invitrogen Corporation Metodos para la produccion de proteinas.
US6635443B1 (en) 1997-09-17 2003-10-21 Human Genome Sciences, Inc. Polynucleotides encoding a novel interleukin receptor termed interleukin-17 receptor-like protein
DE69839060T2 (de) 1997-11-03 2009-01-15 Human Genome Sciences, Inc. Vegi, ein inhibitor der angiogenese und des tumorwachstums
US6190920B1 (en) 1997-11-12 2001-02-20 The Regents Of The University Of California Method for detecting enzyme catalyzed cyclization
AU1417999A (en) * 1997-11-21 1999-06-15 Human Genome Sciences, Inc. Chemokine alpha-5
JP2002506625A (ja) 1998-03-19 2002-03-05 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド サイトカインレセプター共通γ鎖様
ES2312218T3 (es) * 1998-11-13 2009-02-16 Pepscan Systems B.V. Metodo para determinar una secuencia mimotopo.
CA2363779A1 (en) 1999-02-26 2000-08-31 Human Genome Sciences, Inc. Human endokine alpha and methods of use
US6515131B2 (en) 2000-02-22 2003-02-04 Biostream Therapeutics, Inc. Imagining agents for diagnosis of Parkinson's disease
US20030129724A1 (en) 2000-03-03 2003-07-10 Grozinger Christina M. Class II human histone deacetylases, and uses related thereto
US7550425B2 (en) * 2000-06-16 2009-06-23 Zealand Pharma A/S Diuretic peptide conjugates
US20020155455A1 (en) * 2000-08-11 2002-10-24 Invitrogen Corporation Highly homogeneous molecular markers for electrophoresis
EP2123749A3 (de) 2001-02-23 2010-02-24 DSM IP Assets B.V. Neuartige Gene zur Kodierung von neuartigen proteolytischen Enzymen
ATE497603T1 (de) 2001-03-02 2011-02-15 Gpc Biotech Ag Drei-hybrid-assaysystem
EP1363954B1 (de) 2001-03-02 2012-10-17 University of Western Ontario Polymerische vorläufer radiomarkierter verbindungen, und verfahren zu deren herstellung und deren verwendung
AU2002257142B2 (en) 2001-04-13 2008-09-04 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
US7244853B2 (en) 2001-05-09 2007-07-17 President And Fellows Of Harvard College Dioxanes and uses thereof
WO2003076585A2 (en) * 2002-03-08 2003-09-18 Board Of Regents, The University Of Texas System Controlled modulation of amino acid side chain length of peptide antigens
JP4846199B2 (ja) 2002-03-11 2011-12-28 モレキュラ インサイト ファーマシューティカルズ インコーポレイテッド テクネチウム−ジビリジン複合体、およびその使用法
DE60333629D1 (de) 2002-05-21 2010-09-16 Dsm Ip Assets Bv Neue phospholipasen und deren verwendungen
PL214792B1 (pl) 2002-08-19 2013-09-30 Dsm Ip Assets Bv Wyizolowane polinukleotydy, wektor, wyizolowane enzymy lipolityczne, sposób wytwarzania enzymów lipolitycznych, rekombinowane komórki gospodarza, sposób wytwarzania ciasta, sposób wytwarzania wyrobu piekarniczego oraz zastosowanie enzymu lipolitycznego
DK1581467T3 (en) 2002-12-09 2016-11-28 Massachusetts Inst Technology LIGANDS FOR METALS AND IMPROVED METAL CATALYZED PROCEDURES BASED ON THERE
CA2524466C (en) 2003-05-02 2013-11-12 The University Of Western Ontario Prosthetic groups useful in the synthesis of radiopharmaceutical compounds
US20100311641A1 (en) * 2003-09-08 2010-12-09 E. I. Du Pont De Nemours And Company Peptide-based body surface coloring reagents
BRPI0406215A (pt) 2003-09-08 2005-08-09 Du Pont Peptìdeos, condicionadores, colorantes, composições para o cuidado do cabelo e pele, composições cosméticas, composição para o polimento da unha, método para a geração de um peptìdeo, métodos para a formação de uma camada protetora e métodos para a coloração dos cabelos, das unhas, da pele ou lábios e das sobrancelhas ou cìlios
US7285264B2 (en) * 2003-09-08 2007-10-23 E.I. Du Pont De Nemours And Company Peptide-based body surface coloring reagents
US7220405B2 (en) * 2003-09-08 2007-05-22 E. I. Du Pont De Nemours And Company Peptide-based conditioners and colorants for hair, skin, and nails
US7585495B2 (en) 2003-09-08 2009-09-08 E. I. Du Pont De Nemours And Company Method for identifying shampoo-resistant hair-binding peptides and hair benefit agents therefrom
US7807141B2 (en) 2003-09-08 2010-10-05 E.I. Du Pont De Nemours And Company Peptide-based oral care surface reagents for personal care
US20050226839A1 (en) * 2003-09-08 2005-10-13 Xueying Huang Pepetide-based body surface reagents for personal care
US7309482B2 (en) * 2003-09-08 2007-12-18 E.I. Du Pont De Nemours And Company Long lasting waterproof sunscreen comprising metal oxide and peptide conditioner
CA2825161C (en) 2004-02-24 2016-10-04 The General Hospital Corporation Catalytic radiofluorination
US20050261474A1 (en) * 2004-05-20 2005-11-24 Mixture Sciences, Inc. Method of support-based chemical synthesis
WO2006012451A2 (en) 2004-07-22 2006-02-02 Five Prime Therapeutics, Inc. Compositions and methods of use for mgd-csf in disease treatment
CN102351862A (zh) * 2005-02-18 2012-02-15 表面线段公司 药动学改善的化合物
US20110172422A1 (en) * 2005-02-18 2011-07-14 Surface Logix, Inc. Methods of Making Pharmacokinetically Improved Compounds Comprising Functional Residues or Groups and Pharmaceutical Compositions Comprising Said Compounds
US20080274557A1 (en) * 2005-03-03 2008-11-06 Indiana University Research And Technology Permethylation Of Oligosaccharides
CN101495116A (zh) * 2005-03-22 2009-07-29 哈佛大学校长及研究员协会 蛋白降解病症的治疗
US8945573B2 (en) 2005-09-08 2015-02-03 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Targeted identification of immunogenic peptides
US20070065387A1 (en) * 2005-09-16 2007-03-22 Beck William A Method for enhancing the effect of particulate benefit agents
US7736633B2 (en) 2005-09-28 2010-06-15 E.I. Du Pont De Nemours And Company Method for enhancing effects of colorants and conditioners
US7709601B2 (en) * 2005-12-15 2010-05-04 E. I. Du Pont De Nemours And Company Nylon binding peptides and methods of use
US7632919B2 (en) * 2005-12-15 2009-12-15 E.I. Du Pont De Nemours And Company Polystyrene binding peptides and methods of use
US7858581B2 (en) * 2005-12-15 2010-12-28 E. I. Du Pont De Nemours And Company PMMA binding peptides and methods of use
US7928076B2 (en) * 2005-12-15 2011-04-19 E. I. Du Pont De Nemours And Company Polypropylene binding peptides and methods of use
US7906617B2 (en) 2005-12-15 2011-03-15 E. I. Du Pont De Nemours And Company Polyethylene binding peptides and methods of use
US7700716B2 (en) * 2005-12-15 2010-04-20 E. I. Du Pont De Nemours And Company Polytetrafluoroethylene binding peptides and methods of use
US20120208824A1 (en) 2006-01-20 2012-08-16 Cell Signaling Technology, Inc. ROS Kinase in Lung Cancer
CN101528921B (zh) 2006-01-20 2013-11-20 细胞信号技术有限公司 人非小细胞肺癌中的易位和突变的ros激酶
CN101528679A (zh) 2006-02-14 2009-09-09 哈佛大学校长及研究员协会 组蛋白去乙酰化酶抑制剂
US8222423B2 (en) * 2006-02-14 2012-07-17 Dana-Farber Cancer Institute, Inc. Bifunctional histone deacetylase inhibitors
US7749957B2 (en) 2006-04-06 2010-07-06 E.I. Du Pont De Nemours And Company Clay-binding peptides and methods of use
EP2447359B1 (de) 2006-04-14 2015-11-04 Cell Signaling Technology, Inc. Gendefekte und mutierte ALK-Kinase in festen menschlichen Tumoren
JP5497431B2 (ja) 2006-05-03 2014-05-21 プレジデント アンド フェローズ オブ ハーバード カレッジ ヒストンデアセチラーゼおよびチューブリンデアセチラーゼ阻害剤
BRPI0716571A2 (pt) * 2006-08-24 2013-11-05 Surface Logix Inc Compostos farmacocineticamente otimizados
US20100234568A1 (en) * 2006-10-19 2010-09-16 Linda Jane Decarolis Identification of peptide tags for the production of insoluble peptides by sequence scanning
US7662913B2 (en) 2006-10-19 2010-02-16 E. I. Du Pont De Nemours And Company Cystatin-based peptide tags for the expression and purification of bioactive peptides
US7732569B2 (en) 2006-10-19 2010-06-08 E.I. Du Pont De Nemours And Company Zein-based peptide tags for the expression and purification of bioactive peptides
JP2010511637A (ja) * 2006-12-06 2010-04-15 南▲開▼大学 ポリペプチド系重合体およびその合成方法
WO2008100596A2 (en) * 2007-02-15 2008-08-21 Burnham Institute For Medical Research Biomarkers of neurodegenerative disease
US7951559B2 (en) * 2007-07-25 2011-05-31 E.I. Du Pont De Nemours And Company Recombinant peptide production using a cross-linkable solubility tag
US7829311B2 (en) 2007-07-25 2010-11-09 E.I. Du Pont De Nemours And Company Ketosteroid isomerase inclusion body tag engineered to be acid-resistant by replacing aspartates with glutamate
US7678883B2 (en) * 2007-07-25 2010-03-16 E.I. Du Pont De Nemours And Company Solubility tags for the expression and purification of bioactive peptides
WO2009020632A1 (en) 2007-08-06 2009-02-12 Burnham Institute For Medical Research Znf206: a novel regulator of embryonic stem cell self-renewal and pluripotency
AU2008314567B2 (en) 2007-10-18 2014-11-20 Cell Signaling Technology, Inc. Translocation and mutant ROS kinase in human non-small cell lung carcinoma
US7794963B2 (en) 2007-11-02 2010-09-14 E.I. Du Pont De Nemours And Company Use of tetracysteine tags in fluorescence-activated cell sorting analysis of prokaryotic cells producing peptides or proteins
RU2515611C2 (ru) 2008-07-23 2014-05-20 Президент Энд Феллоуз Оф Гарвард Колледж Ингибиторы деацетилазы и их применение
US20100158822A1 (en) * 2008-12-18 2010-06-24 E .I. Du Pont De Nemours And Company Peptides that bind to silica-coated particles
US8287845B2 (en) * 2008-12-18 2012-10-16 E I Du Pont De Nemours And Company Hair-binding peptides
US20100158837A1 (en) 2008-12-18 2010-06-24 E. I. Du Pont De Nemours And Company Iron oxide-binding peptides
US20100158846A1 (en) * 2008-12-18 2010-06-24 E. I. Du Pont De Nemours And Company Hair-binding peptides
AU2010213578B2 (en) 2009-02-12 2015-01-29 Cell Signaling Technology, Inc. Mutant ROS expression in human cancer
US8481678B2 (en) 2009-03-30 2013-07-09 E I Du Pont De Nemours And Company Peptide-based tooth whitening reagents
CA2758049A1 (en) 2009-03-30 2010-10-14 E.I. Du Pont De Nemours And Company Peptide-based systems for delivery of cosmetic agents
CA2767646C (en) 2009-07-10 2019-01-29 President And Fellows Of Harvard College Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
US8716344B2 (en) 2009-08-11 2014-05-06 President And Fellows Of Harvard College Class- and isoform-specific HDAC inhibitors and uses thereof
AU2010287069B2 (en) 2009-08-27 2016-07-07 Lucidome Bio Limited Complete genome sequence of the methanogen Methanobrevibacter ruminantium
WO2012019132A2 (en) 2010-08-06 2012-02-09 Cell Signaling Technology, Inc. Anaplastic lymphoma kinase in kidney cancer
US20150056193A1 (en) 2012-04-18 2015-02-26 Cell Signaling Technology, Inc. Egfr and ros1 kinase in cancer
US10155987B2 (en) 2012-06-12 2018-12-18 Dana-Farber Cancer Institute, Inc. Methods of predicting resistance to JAK inhibitor therapy
CA2994545A1 (en) 2015-08-03 2017-02-09 President And Fellows Of Harvard College Charged ion channel blockers and methods for use
US10934263B2 (en) 2019-03-11 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
MX2021010870A (es) 2019-03-11 2022-01-19 Nocion Therapeutics Inc Bloqueadores de canales ionicos cargados y metodos de uso.
US10828287B2 (en) 2019-03-11 2020-11-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
KR102887727B1 (ko) 2019-03-11 2025-11-18 녹시온 테라퓨틱스 인코포레이티드 에스테르 치환된 이온 채널 차단제 및 사용 방법
EP4054586A4 (de) 2019-11-06 2023-11-22 Nocion Therapeutics, Inc. Geladene ionenkanalblocker und verfahren zur verwendung
AU2020380118A1 (en) 2019-11-06 2022-05-19 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CN114845986B (zh) * 2019-12-17 2025-10-28 迈图高新材料有限责任公司 用于处理基于氨基酸的纤维状基质、尤其是头发的聚合物型脂肪酸化合物
US11332446B2 (en) 2020-03-11 2022-05-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US12162851B2 (en) 2020-03-11 2024-12-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984003506A1 (en) * 1983-03-08 1984-09-13 Commw Serum Lab Commission Antigenically active amino acid sequences
NZ207394A (en) * 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
EP0138854B1 (de) * 1983-03-08 1992-11-04 Chiron Mimotopes Pty. Ltd. Antigen aktive aminosäuresequenzen
US4631211A (en) * 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
NZ215865A (en) * 1985-04-22 1988-10-28 Commw Serum Lab Commission Method of determining the active site of a receptor-binding analogue
US5294392A (en) * 1985-05-15 1994-03-15 E. I. Du Pont De Nemours And Company Method of making bonded non-woven polyester fiber structures using fiberballs
US5010175A (en) * 1988-05-02 1991-04-23 The Regents Of The University Of California General method for producing and selecting peptides with specific properties
CZ280777B6 (cs) * 1990-02-02 1996-04-17 Ústav Organické Chemie A Biochemie Avčr Mnohonásobná automatizovaná syntéza peptidů na planárních nosičích
US5182366A (en) * 1990-05-15 1993-01-26 Huebner Verena D Controlled synthesis of peptide mixtures using mixed resins
IE66205B1 (en) * 1990-06-14 1995-12-13 Paul A Bartlett Polypeptide analogs
US5650489A (en) * 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
DK0558671T3 (da) * 1990-11-21 1999-09-13 Iterex Pharma Lp Syntese af ækvimolære multiple oligomerblandinger, især af oligopeptidblandinger

Also Published As

Publication number Publication date
EP0722458A4 (de) 1999-05-19
AU694438B2 (en) 1998-07-23
US5763193A (en) 1998-06-09
WO1995000539A1 (en) 1995-01-05
US5480971A (en) 1996-01-02
DE69430312T2 (de) 2002-10-02
AU7171994A (en) 1995-01-17
EP0722458A1 (de) 1996-07-24
CA2165561C (en) 2000-05-16
DE69430312D1 (de) 2002-05-08
EP0722458B1 (de) 2002-04-03
CA2165561A1 (en) 1995-01-05

Similar Documents

Publication Publication Date Title
ATE215559T1 (de) Peralkylierte oligopeptidmischungen
ES2129442T3 (es) Sintesis de mezclas de oligomeros multiples equimolares, especialmente de mezclas oligopeptidicas.
DE69426885D1 (de) Linear substituierte oligoalkylenimin-bibliotheken
DK0583814T3 (da) Termoviskositetsforøgende polymerer, deres syntese og deres anvendelser i især olieindustrien
DK0430863T4 (da) Kaskadepolymer-komplekser, anvendelse deraf og farmaceutiske midler der indeholder dem
FI961147A7 (fi) Kopolyymereja sekä niiden amiinien kanssa muodostamia reaktiotuotteita , jotka ovat käyttökelpoisia poltto- ja voiteluaineiden lisäaineina
DE69428420D1 (de) Globale Adressierung für selbsttaktierende Strichkodes
DE69404776D1 (de) Etikett für verpackte Produkte
FI940012A0 (fi) Aryylisulfonamidosubstituoidut hydroksaamihapot
DE60140141D1 (de) Zusammensetzungen umfassend Komplexe von Tocopherolphosphatderivaten
CY1108465T1 (el) Μεθοδος συνθεσης πεπτιδιων στερεης φασης
BR9401284A (pt) Agitador para misturar ou combinar vários produtos
IL103365A0 (en) Latent thiol mercaptan chain transfer agents and their use in the synthesis of polymers
BG99521A (en) Preparation of n-substituted oligomers
FI933215L (fi) Kasvin fosforin saantia parantava lannoitevalmiste
DK0476038T3 (da) Kemiske produkter
ITFI930083A1 (it) Composti pirrol-amidinici, processi di preparazione e composizioni farmaceutiche che li contengono.
ES525553A0 (es) Procedimiento para la fabricacion de derivados peptidicos inhibidores de proteasas acidas
TR28158A (tr) Krom katalizör kompozisyonlari ve bunlarin kullanildigi polimerizasyon prosesleri.
DE69915103D1 (de) Neue oligomere konjugate zum transfer biologischer moleküle in zellen
DK0697891T3 (da) Polyoximforbindelser og fremstilling deraf
ATE336501T1 (de) Chi-conotoxinpeptide als inhibitoren neuronaler amintransporter
ES2111607T3 (es) Composiciones detergentes para inhibir la transferencia de colorante.
DE69838459D1 (de) Für den licht-überempfinlichkeitsphaenotyp kodierende nukleotidsequenzen von tomaten, dadurch kodierte proteine und deren verwendungen
NO944668L (no) Dobbeltkjedete peptidforbindelser med hemoregulatorisk aktivitet

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties